NCT00837915View on ClinicalTrials.gov

Bioequivalnce Study of Loratadine / Pseudoephedrine Sulfate 10/ 240 mg Extended-Release Tablets Under Fasting Conditions

NACompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

June 30, 2002

Primary Completion Date

August 31, 2002

Study Completion Date

November 30, 2002

Conditions
Healthy
Interventions
DRUG

Loratadine 10mg /Pseudoephedrine Sulfate 240 mg Extended-Release Tablets

Trial Locations (1)

H4R2N6

MDS Pharma Services, Montreal

All Listed Sponsors
lead

Ranbaxy Laboratories Limited

INDUSTRY

NCT00837915 - Bioequivalnce Study of Loratadine / Pseudoephedrine Sulfate 10/ 240 mg Extended-Release Tablets Under Fasting Conditions | Biotech Hunter | Biotech Hunter